Description
Product Description
Multi-dose 16 mg – Retatrutide pen that delivers doses in ( .50 mg / 1 mg / 2 mg / 3 mg )
Contains (1) – 16 mg/3 ml Prefilled retatrutide pen
Contains (6) – 32 gauge needles
Retaject is ready to use straight out of the box – no mixing or preparation required.
Refrigerate for maximum shelf life
Please note the product dial is in IU (international units), dosing increments can be adjusted using the dial for precise measurement based on required research applications
Retatrutide: Next-Generation Triple Agonist Compound
Product Overview
Retatrutide represents the next evolution in metabolic research compounds. Designed to engage multiple regulatory pathways simultaneously, it offers a more advanced approach compared to single-pathway alternatives.
Currently under investigation in clinical research settings, this compound has drawn significant attention for its broad-spectrum activity across key metabolic systems.
How It Works
Retatrutide is classified as a triple agonist, interacting with GLP-1, GIP, and glucagon receptors — three critical pathways involved in energy balance and metabolic signaling.
By engaging multiple pathways at once, research suggests a more comprehensive approach to system-wide regulation compared to traditional single-receptor compounds.
Key areas of ongoing research include:
Multi-Pathway Activation: Simultaneous interaction across GLP-1, GIP, and glucagon receptors for expanded signaling coverage.
Metabolic Regulation: Under investigation for its role in influencing energy balance and nutrient processing pathways.
Extended Activity Profile: Designed for sustained interaction within biological systems under controlled research conditions.
Retaject delivers a streamlined, ready-to-use format for advanced research applications — combining precision, convenience, and next-generation compound design in one system.
Daniel K. –
Been waiting for this release, Glad to see it finally available